Bristol-Myers Squibb Ce
(CELG-RI)
undefined
undefined%
At close: undefined
Company Description
No Company description available at the moment.
Bristol-Myers Squibb Ce
| Country | n/a |
| IPO Date | n/a |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | n/a |
| CEO | n/a |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | CELG-RI |
| Exchange | NYSE |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0000014272 |
| CUSIP Number | n/a |
| ISIN Number | US1101221406 |
| Employer ID | 22-0790350 |
| SIC Code | 2834 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 05, 2024 | 4 | Filing |
| Nov 05, 2024 | 4 | Filing |
| Nov 05, 2024 | 4 | Filing |
| Nov 05, 2024 | 4 | Filing |
| Nov 05, 2024 | 4 | Filing |
| Oct 31, 2024 | 10-Q | Quarterly Report |